BR0214570A - Prevenção do aborto com compostos imunomodulantes de gestageno não-endógeno - Google Patents
Prevenção do aborto com compostos imunomodulantes de gestageno não-endógenoInfo
- Publication number
- BR0214570A BR0214570A BR0214570-7A BR0214570A BR0214570A BR 0214570 A BR0214570 A BR 0214570A BR 0214570 A BR0214570 A BR 0214570A BR 0214570 A BR0214570 A BR 0214570A
- Authority
- BR
- Brazil
- Prior art keywords
- abortion
- prevention
- endogenous
- gestomene
- immunomodulatory compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
"PREVENçãO DO ABORTO COM COMPOSTOS IMUNOMODULANTES DE GESTAGENO NãO-ENDóGENO". A presente invenção refere-se à utilização de compostos de gestageno não-endógenos imunologicamente ativos, no tratamento e/ou profilaxia de aborto espontâneo ou habitual.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33412401P | 2001-11-30 | 2001-11-30 | |
PCT/EP2002/013288 WO2003045361A1 (en) | 2001-11-30 | 2002-11-26 | Prevention of miscarriage with immunomodulating non-endogenous gestagen compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0214570A true BR0214570A (pt) | 2004-11-03 |
Family
ID=23305691
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0214570-7A Withdrawn BR0214570A (pt) | 2001-11-30 | 2002-11-26 | Prevenção do aborto com compostos imunomodulantes de gestageno não-endógeno |
Country Status (8)
Country | Link |
---|---|
US (1) | US20050020553A1 (pt) |
EP (1) | EP1448178A1 (pt) |
CN (1) | CN1596107A (pt) |
AU (1) | AU2002365512A1 (pt) |
BR (1) | BR0214570A (pt) |
PL (1) | PL368744A1 (pt) |
RU (1) | RU2004120066A (pt) |
WO (1) | WO2003045361A1 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005078469A1 (en) * | 2004-02-04 | 2005-08-25 | E.I. Dupont De Nemours And Company | The use of two or more sensors to detect different nuclear quadrupole resonance signals of a target compound |
US8951996B2 (en) | 2011-07-28 | 2015-02-10 | Lipocine Inc. | 17-hydroxyprogesterone ester-containing oral compositions and related methods |
US10285998B1 (en) | 2018-04-04 | 2019-05-14 | The Menopause Method, Inc. | Composition and method to aid in hormone replacement therapy |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6954494A (en) * | 1993-05-21 | 1994-12-20 | Brigham And Women's Hospital | Embryotoxic factors |
DE4336343C2 (de) * | 1993-10-25 | 1996-07-25 | Mucos Pharma Gmbh & Co | Verwendung von proteolytischen Enzymen zur Abortprophylaxe bei Schwangeren mit idiopathischem Abortus habitualis in der Anamnese |
-
2002
- 2002-11-26 EP EP02790437A patent/EP1448178A1/en not_active Withdrawn
- 2002-11-26 RU RU2004120066/14A patent/RU2004120066A/ru not_active Application Discontinuation
- 2002-11-26 AU AU2002365512A patent/AU2002365512A1/en not_active Abandoned
- 2002-11-26 BR BR0214570-7A patent/BR0214570A/pt not_active Withdrawn
- 2002-11-26 PL PL02368744A patent/PL368744A1/xx not_active Application Discontinuation
- 2002-11-26 CN CNA028237439A patent/CN1596107A/zh active Pending
- 2002-11-26 WO PCT/EP2002/013288 patent/WO2003045361A1/en not_active Application Discontinuation
-
2004
- 2004-05-28 US US10/855,789 patent/US20050020553A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
RU2004120066A (ru) | 2005-04-10 |
US20050020553A1 (en) | 2005-01-27 |
CN1596107A (zh) | 2005-03-16 |
WO2003045361A1 (en) | 2003-06-05 |
EP1448178A1 (en) | 2004-08-25 |
AU2002365512A1 (en) | 2003-06-10 |
PL368744A1 (en) | 2005-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0025173D0 (en) | Therapeutic agents | |
CA2384504A1 (en) | Use of retigabin for treating neuropathic pain | |
BG108269A (en) | Pyrazolopyrimidines as therapeutic agents | |
AU4086101A (en) | Sulphonamido-substituted bridged bicycloalkyl derivatives | |
BR0210205A (pt) | Antiinfecciosos | |
GB0005251D0 (en) | Therapeutic compounds | |
WO2002067807A3 (en) | Animal garment | |
BR0211769A (pt) | Combinações antineoplásicas | |
ZA200300712B (en) | Pharmaceutical compositions for the treatment of mucositis, stomatitis and Behcet's syndrome. | |
WO1999047131A3 (en) | Combination of a gaba-a alpha 5 inverse agonist and an acetylcholinesterase inhibitor | |
DE60010260D1 (de) | Hydrierte blockcopolymerzusammensetzungen und verwendungen davon | |
AU2001279703A1 (en) | Garment | |
HK1068106A1 (en) | Use of sarp-1 for the treatment and/or prevention of scleroderma | |
MY121864A (en) | Condensed thienopyrimidines with phosphodiesterase-v inhibiting action. | |
TR200402670T4 (tr) | Obezitenin tedavisi ve/veya profilaksına uygun bileşiklerin bulunması için yöntem | |
MXPA03011123A (es) | Almohadilla labial que tiene varios medios. | |
WO2001009122A3 (en) | Serotonergic benzofurans | |
BR0214570A (pt) | Prevenção do aborto com compostos imunomodulantes de gestageno não-endógeno | |
ES2175356T3 (es) | Uso de (+)-alfa-(2,3-dimetoxifenil)-1-[2-(4 fluorofenil)et il[-4- piperidinmetanol en el tratamiento de trastornos depresivos y trastornos bipolares. | |
DK0813870T3 (da) | Anvendelse af darifenacin til at forstærke kognitive funktioner | |
BR9810556A (pt) | Beta-alcoxiacrilatos contra a malária | |
PL331882A1 (en) | Substituted 1,2,3,4-tetrahydro-2-dibenzofurane amines and 2-amino cyclohepta[b]benzofuranes | |
BG104914A (en) | Paroxetine maleate | |
BR0114065A (pt) | Triazolo-epotilonas | |
FI19992274A (fi) | Liitosyhde |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A E 7A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2064 DE 27/07/2010. |